These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25099012)

  • 21. Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors.
    Yoon K; Lee SO; Cho SD; Kim K; Khan S; Safe S
    Carcinogenesis; 2011 Jun; 32(6):836-42. PubMed ID: 21362629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model.
    Andey T; Patel A; Jackson T; Safe S; Singh M
    Eur J Pharm Sci; 2013 Oct; 50(2):227-41. PubMed ID: 23892137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells.
    Shrestha R; Mohankumar K; Jin UH; Martin G; Safe S
    Mol Cancer Ther; 2021 Mar; 20(3):612-622. PubMed ID: 33277444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells.
    Mohankumar K; Shrestha R; Safe S
    Mol Carcinog; 2022 Jan; 61(1):73-84. PubMed ID: 34699643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Drug Candidate Targeting the 4A1 Orphan Nuclear Receptor for Medullary Thyroid Cancer Therapy.
    Zhang L; Liu W; Wang Q; Li Q; Wang H; Wang J; Teng T; Chen M; Ji A; Li Y
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.
    Lei P; Abdelrahim M; Cho SD; Liu S; Chintharlapalli S; Safe S
    Carcinogenesis; 2008 Jun; 29(6):1139-47. PubMed ID: 18460448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity.
    Karki K; Wright GA; Mohankumar K; Jin UH; Zhang XH; Safe S
    Cancer Res; 2020 Mar; 80(5):1011-1023. PubMed ID: 31911554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
    Chintharlapalli S; Smith R; Samudio I; Zhang W; Safe S
    Cancer Res; 2004 Sep; 64(17):5994-6001. PubMed ID: 15342379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGFβ-Induced Lung Cancer Cell Migration Is NR4A1-Dependent.
    Hedrick E; Mohankumar K; Safe S
    Mol Cancer Res; 2018 Dec; 16(12):1991-2002. PubMed ID: 30072581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of COUP-TFI by a Novel Diindolylmethane Derivative.
    Yoon K; Chen CC; Orr AA; Barreto PN; Tamamis P; Safe S
    Cells; 2019 Mar; 8(3):. PubMed ID: 30866413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p21 expression is induced by activation of nuclear nerve growth factor-induced Balpha (Nur77) in pancreatic cancer cells.
    Lee SO; Chintharlapalli S; Liu S; Papineni S; Cho SD; Yoon K; Safe S
    Mol Cancer Res; 2009 Jul; 7(7):1169-78. PubMed ID: 19584258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.
    Safe S; Papineni S; Chintharlapalli S
    Cancer Lett; 2008 Oct; 269(2):326-38. PubMed ID: 18501502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells.
    Li X; Lee SO; Safe S
    Biochem Pharmacol; 2012 May; 83(10):1445-55. PubMed ID: 22405837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways.
    Chintharlapalli S; Papineni S; Safe S
    Mol Cancer Ther; 2006 May; 5(5):1362-70. PubMed ID: 16731770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1.
    Lacey A; Rodrigues-Hoffman A; Safe S
    Cancer Res; 2017 Feb; 77(3):732-741. PubMed ID: 27864345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidized analogs of Di(1
    Sanchez M; Xia Z; Rico-Bautista E; Cao X; Cuddy M; Castro DJ; Correa RG; Chen L; Yu J; Bobkov A; Ruvolo V; Andreeff M; Oshima RG; Matsuzawa SI; Reed JC; Zhang XK; Hansel D; Wolf DA; Dawson MI
    Oncotarget; 2018 May; 9(38):25057-25074. PubMed ID: 29861853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion.
    Mohankumar K; Wright G; Kumaravel S; Shrestha R; Zhang L; Abdelrahim M; Chapkin RS; Safe S
    Cancer Immunol Immunother; 2023 Dec; 72(12):3985-3999. PubMed ID: 37847301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.
    Goldberg AA; Titorenko VI; Beach A; Abdelbaqi K; Safe S; Sanderson JT
    Invest New Drugs; 2014 Feb; 32(1):25-36. PubMed ID: 23709189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orphan nuclear receptor 4A1 (NR4A1) and novel ligands.
    Safe S; Shrestha R; Mohankumar K
    Essays Biochem; 2021 Dec; 65(6):877-886. PubMed ID: 34096590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming Growth Factor β/NR4A1-Inducible Breast Cancer Cell Migration and Epithelial-to-Mesenchymal Transition Is p38α (Mitogen-Activated Protein Kinase 14) Dependent.
    Hedrick E; Safe S
    Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28674186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.